CHEMOURS CO/THE (CC) Fundamental Analysis & Valuation

NYSE:CC • US1638511089

16.75 USD
-0.78 (-4.45%)
At close: Mar 5, 2026
16.75 USD
0 (0%)
After Hours: 3/5/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, CC scores 3 out of 10 in our fundamental rating. CC was compared to 83 industry peers in the Chemicals industry. CC has a bad profitability rating. Also its financial health evaluation is rather negative. CC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. CC Profitability Analysis

1.1 Basic Checks

  • In the past year CC was profitable.
  • In the past year CC had a positive cash flow from operations.
  • In multiple years CC reported negative net income over the last 5 years.
  • Of the past 5 years CC 4 years had a positive operating cash flow.
CC Yearly Net Income VS EBIT VS OCF VS FCFCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • CC has a Return On Assets of -5.23%. This is in the lower half of the industry: CC underperforms 72.29% of its industry peers.
  • CC has a worse Return On Equity (-154.40%) than 92.77% of its industry peers.
Industry RankSector Rank
ROA -5.23%
ROE -154.4%
ROIC N/A
ROA(3y)-2.46%
ROA(5y)1.65%
ROE(3y)-58.88%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
CC Yearly ROA, ROE, ROICCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • CC has a worse Gross Margin (15.55%) than 75.90% of its industry peers.
  • CC's Gross Margin has declined in the last couple of years.
  • CC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.27%
CC Yearly Profit, Operating, Gross MarginsCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CC Health Analysis

2.1 Basic Checks

  • CC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CC has been increased compared to 1 year ago.
  • Compared to 5 years ago, CC has less shares outstanding
  • The debt/assets ratio for CC is higher compared to a year ago.
CC Yearly Shares OutstandingCC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CC Yearly Total Debt VS Total AssetsCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CC has an Altman-Z score of 1.45. This is a bad value and indicates that CC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CC (1.45) is worse than 65.06% of its industry peers.
  • The Debt to FCF ratio of CC is 81.20, which is on the high side as it means it would take CC, 81.20 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 81.20, CC is doing worse than 61.45% of the companies in the same industry.
  • A Debt/Equity ratio of 16.40 is on the high side and indicates that CC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 16.40, CC is doing worse than 93.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 16.4
Debt/FCF 81.2
Altman-Z 1.45
ROIC/WACCN/A
WACC8.92%
CC Yearly LT Debt VS Equity VS FCFCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that CC should not have too much problems paying its short term obligations.
  • CC's Current ratio of 1.78 is in line compared to the rest of the industry. CC outperforms 46.99% of its industry peers.
  • A Quick Ratio of 0.85 indicates that CC may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.85, CC is doing worse than 74.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.85
CC Yearly Current Assets VS Current LiabilitesCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CC Growth Analysis

3.1 Past

  • CC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.66%.
  • The earnings per share for CC have been decreasing by -13.39% on average. This is quite bad
  • Looking at the last year, CC shows a small growth in Revenue. The Revenue has grown by 0.43% in the last year.
  • CC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.17% yearly.
EPS 1Y (TTM)-20.66%
EPS 3Y-40.64%
EPS 5Y-13.39%
EPS Q2Q%-54.55%
Revenue 1Y (TTM)0.43%
Revenue growth 3Y-5.09%
Revenue growth 5Y3.17%
Sales Q2Q%-4.59%

3.2 Future

  • CC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.91% yearly.
  • Based on estimates for the next years, CC will show a small growth in Revenue. The Revenue will grow by 4.65% on average per year.
EPS Next Y85.34%
EPS Next 2Y59.29%
EPS Next 3Y49.91%
EPS Next 5YN/A
Revenue Next Year4.03%
Revenue Next 2Y4.42%
Revenue Next 3Y4.65%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CC Yearly Revenue VS EstimatesCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
CC Yearly EPS VS EstimatesCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. CC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.45, which indicates a rather expensive current valuation of CC.
  • 61.45% of the companies in the same industry are more expensive than CC, based on the Price/Earnings ratio.
  • CC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 9.41, the valuation of CC can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CC is valued cheaply inside the industry as 89.16% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, CC is valued rather cheaply.
Industry RankSector Rank
PE 17.45
Fwd PE 9.41
CC Price Earnings VS Forward Price EarningsCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CC is valued a bit more expensive than 67.47% of the companies in the same industry.
  • CC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.23
EV/EBITDA 18.15
CC Per share dataCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CC's earnings are expected to grow with 49.91% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y59.29%
EPS Next 3Y49.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CC Dividend Analysis

5.1 Amount

  • CC has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.
  • CC's Dividend Yield is a higher than the industry average which is at 2.19.
  • Compared to an average S&P500 Dividend Yield of 1.82, CC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

  • The dividend of CC decreases each year by -12.19%.
  • CC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CC has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-12.19%
Div Incr Years0
Div Non Decr Years8
CC Yearly Dividends per shareCC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • CC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-20.21%
EPS Next 2Y59.29%
EPS Next 3Y49.91%
CC Yearly Income VS Free CF VS DividendCC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

More info and screens

Find the best dividend stocksShow peers with best dividend

CC Fundamentals: All Metrics, Ratios and Statistics

CHEMOURS CO/THE

NYSE:CC (3/5/2026, 8:04:00 PM)

After market: 16.75 0 (0%)

16.75

-0.78 (-4.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-19
Earnings (Next)05-04
Inst Owners96.18%
Inst Owner Change-4.91%
Ins Owners0.43%
Ins Owner Change0.08%
Market Cap2.51B
Revenue(TTM)5.81B
Net Income(TTM)-386.00M
Analysts75.56
Price Target19 (13.43%)
Short Float %9.36%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0.52
Dividend Growth(5Y)-12.19%
DP-20.21%
Div Incr Years0
Div Non Decr Years8
Ex-Date02-27
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.25%
Min EPS beat(2)-29.07%
Max EPS beat(2)-23.42%
EPS beat(4)1
Avg EPS beat(4)-17.47%
Min EPS beat(4)-40.66%
Max EPS beat(4)23.28%
EPS beat(8)3
Avg EPS beat(8)-0.86%
EPS beat(12)5
Avg EPS beat(12)8.59%
EPS beat(16)8
Avg EPS beat(16)6.26%
Revenue beat(2)0
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)-2.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)0.19%
Revenue beat(8)2
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-1.68%
Revenue beat(16)8
Avg Revenue beat(16)-0.27%
PT rev (1m)18.88%
PT rev (3m)15.5%
EPS NQ rev (1m)-112.68%
EPS NQ rev (3m)-111.95%
EPS NY rev (1m)-1.95%
EPS NY rev (3m)-16.71%
Revenue NQ rev (1m)-1.84%
Revenue NQ rev (3m)-3.16%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE 17.45
Fwd PE 9.41
P/S 0.43
P/FCF 49.23
P/OCF 9.51
P/B 10.04
P/tB 12.43
EV/EBITDA 18.15
EPS(TTM)0.96
EY5.73%
EPS(NY)1.78
Fwd EY10.62%
FCF(TTM)0.34
FCFY2.03%
OCF(TTM)1.76
OCFY10.52%
SpS38.75
BVpS1.67
TBVpS1.35
PEG (NY)0.2
PEG (5Y)N/A
Graham Number6
Profitability
Industry RankSector Rank
ROA -5.23%
ROE -154.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.55%
FCFM 0.88%
ROA(3y)-2.46%
ROA(5y)1.65%
ROE(3y)-58.88%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.27%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 16.4
Debt/FCF 81.2
Debt/EBITDA 12.2
Cap/Depr 62.65%
Cap/Sales 3.67%
Interest Coverage N/A
Cash Conversion 78.57%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.85
Altman-Z 1.45
F-Score4
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)100.92%
Cap/Depr(5y)99.13%
Cap/Sales(3y)5.33%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.66%
EPS 3Y-40.64%
EPS 5Y-13.39%
EPS Q2Q%-54.55%
EPS Next Y85.34%
EPS Next 2Y59.29%
EPS Next 3Y49.91%
EPS Next 5YN/A
Revenue 1Y (TTM)0.43%
Revenue growth 3Y-5.09%
Revenue growth 5Y3.17%
Sales Q2Q%-4.59%
Revenue Next Year4.03%
Revenue Next 2Y4.42%
Revenue Next 3Y4.65%
Revenue Next 5YN/A
EBIT growth 1Y-100.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.22%
EBIT Next 3Y36.61%
EBIT Next 5YN/A
FCF growth 1Y105.14%
FCF growth 3Y-51.5%
FCF growth 5Y-37.62%
OCF growth 1Y141.71%
OCF growth 3Y-29.52%
OCF growth 5Y-20.03%

CHEMOURS CO/THE / CC FAQ

Can you provide the ChartMill fundamental rating for CHEMOURS CO/THE?

ChartMill assigns a fundamental rating of 3 / 10 to CC.


What is the valuation status of CHEMOURS CO/THE (CC) stock?

ChartMill assigns a valuation rating of 6 / 10 to CHEMOURS CO/THE (CC). This can be considered as Fairly Valued.


What is the profitability of CC stock?

CHEMOURS CO/THE (CC) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for CC stock?

The Price/Earnings (PE) ratio for CHEMOURS CO/THE (CC) is 17.45 and the Price/Book (PB) ratio is 10.04.


How financially healthy is CHEMOURS CO/THE?

The financial health rating of CHEMOURS CO/THE (CC) is 1 / 10.